vs
Side-by-side financial comparison of Dolby Laboratories, Inc. (DLB) and Hims & Hers Health, Inc. (HIMS). Click either name above to swap in a different company.
Hims & Hers Health, Inc. is the larger business by last-quarter revenue ($617.8M vs $395.6M, roughly 1.6× Dolby Laboratories, Inc.). Dolby Laboratories, Inc. runs the higher net margin — 24.0% vs 3.3%, a 20.7% gap on every dollar of revenue. On growth, Hims & Hers Health, Inc. posted the faster year-over-year revenue change (28.4% vs 7.1%). Over the past eight quarters, Hims & Hers Health, Inc.'s revenue compounded faster (49.0% CAGR vs 13.9%).
Dolby Laboratories, Inc. is an American technology corporation specializing in audio noise reduction, audio encoding/compression, spatial audio, and high-dynamic-range television (HDR) imaging. Dolby licenses its technologies to consumer electronics manufacturers.
Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.
DLB vs HIMS — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $395.6M | $617.8M |
| Net Profit | $94.9M | $20.6M |
| Gross Margin | 88.7% | 71.9% |
| Operating Margin | 28.5% | 1.5% |
| Net Margin | 24.0% | 3.3% |
| Revenue YoY | 7.1% | 28.4% |
| Net Profit YoY | 3.4% | -20.8% |
| EPS (diluted) | $0.99 | $0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q2 26 | $395.6M | — | ||
| Q1 26 | $346.7M | — | ||
| Q4 25 | $346.7M | $617.8M | ||
| Q3 25 | $307.0M | $599.0M | ||
| Q2 25 | $315.5M | $544.8M | ||
| Q1 25 | $369.6M | $586.0M | ||
| Q4 24 | $357.0M | $481.1M | ||
| Q3 24 | $304.8M | $401.6M |
| Q2 26 | $94.9M | — | ||
| Q1 26 | $53.3M | — | ||
| Q4 25 | $53.3M | $20.6M | ||
| Q3 25 | $49.3M | $15.8M | ||
| Q2 25 | $46.1M | $42.5M | ||
| Q1 25 | $91.8M | $49.5M | ||
| Q4 24 | $67.8M | $26.0M | ||
| Q3 24 | $58.6M | $75.6M |
| Q2 26 | 88.7% | — | ||
| Q1 26 | 87.5% | — | ||
| Q4 25 | 87.5% | 71.9% | ||
| Q3 25 | 87.1% | 73.8% | ||
| Q2 25 | 86.1% | 76.4% | ||
| Q1 25 | 90.3% | 73.5% | ||
| Q4 24 | 88.6% | 76.8% | ||
| Q3 24 | 88.8% | 79.2% |
| Q2 26 | 28.5% | — | ||
| Q1 26 | 17.9% | — | ||
| Q4 25 | 17.9% | 1.5% | ||
| Q3 25 | 9.7% | 2.0% | ||
| Q2 25 | 15.1% | 4.9% | ||
| Q1 25 | 29.2% | 9.9% | ||
| Q4 24 | 22.4% | 3.9% | ||
| Q3 24 | 15.2% | 5.6% |
| Q2 26 | 24.0% | — | ||
| Q1 26 | 15.4% | — | ||
| Q4 25 | 15.4% | 3.3% | ||
| Q3 25 | 16.1% | 2.6% | ||
| Q2 25 | 14.6% | 7.8% | ||
| Q1 25 | 24.8% | 8.4% | ||
| Q4 24 | 19.0% | 5.4% | ||
| Q3 24 | 19.2% | 18.8% |
| Q2 26 | $0.99 | — | ||
| Q1 26 | $0.55 | — | ||
| Q4 25 | $0.55 | $0.08 | ||
| Q3 25 | $0.50 | $0.06 | ||
| Q2 25 | $0.48 | $0.17 | ||
| Q1 25 | $0.94 | $0.20 | ||
| Q4 24 | $0.70 | $0.10 | ||
| Q3 24 | $0.59 | $0.32 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $594.7M | $228.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.6B | $540.9M |
| Total Assets | $3.2B | $2.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q2 26 | $594.7M | — | ||
| Q1 26 | $644.6M | — | ||
| Q4 25 | $644.6M | $228.6M | ||
| Q3 25 | $702.6M | $345.8M | ||
| Q2 25 | $699.3M | $1.1B | ||
| Q1 25 | $626.6M | $273.7M | ||
| Q4 24 | $520.8M | $220.6M | ||
| Q3 24 | $482.0M | $165.5M |
| Q2 26 | $2.6B | — | ||
| Q1 26 | $2.6B | — | ||
| Q4 25 | $2.6B | $540.9M | ||
| Q3 25 | $2.6B | $581.0M | ||
| Q2 25 | $2.6B | $562.7M | ||
| Q1 25 | $2.6B | $549.3M | ||
| Q4 24 | $2.5B | $476.7M | ||
| Q3 24 | $2.5B | $440.1M |
| Q2 26 | $3.2B | — | ||
| Q1 26 | $3.2B | — | ||
| Q4 25 | $3.2B | $2.2B | ||
| Q3 25 | $3.2B | $2.2B | ||
| Q2 25 | $3.2B | $1.9B | ||
| Q1 25 | $3.2B | $891.7M | ||
| Q4 24 | $3.2B | $707.5M | ||
| Q3 24 | $3.1B | $602.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $147.3M | $61.3M |
| Free Cash FlowOCF − Capex | — | $-2.5M |
| FCF MarginFCF / Revenue | — | -0.4% |
| Capex IntensityCapex / Revenue | — | 10.3% |
| Cash ConversionOCF / Net Profit | 1.55× | 2.98× |
| TTM Free Cash FlowTrailing 4 quarters | — | $57.4M |
8-quarter trend — quarters aligned by calendar period.
| Q2 26 | $147.3M | — | ||
| Q1 26 | $54.8M | — | ||
| Q4 25 | $54.8M | $61.3M | ||
| Q3 25 | $472.2M | $148.7M | ||
| Q2 25 | $67.7M | $-19.1M | ||
| Q1 25 | $174.9M | $109.1M | ||
| Q4 24 | $106.8M | $86.4M | ||
| Q3 24 | $327.3M | $85.3M |
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $50.2M | $-2.5M | ||
| Q3 25 | $435.9M | $79.3M | ||
| Q2 25 | $61.3M | $-69.5M | ||
| Q1 25 | $168.0M | $50.1M | ||
| Q4 24 | $100.0M | $59.5M | ||
| Q3 24 | $297.2M | $79.4M |
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 14.5% | -0.4% | ||
| Q3 25 | 142.0% | 13.2% | ||
| Q2 25 | 19.4% | -12.8% | ||
| Q1 25 | 45.5% | 8.5% | ||
| Q4 24 | 28.0% | 12.4% | ||
| Q3 24 | 97.5% | 19.8% |
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 1.3% | 10.3% | ||
| Q3 25 | 11.8% | 11.6% | ||
| Q2 25 | 2.0% | 9.3% | ||
| Q1 25 | 1.9% | 10.1% | ||
| Q4 24 | 1.9% | 5.6% | ||
| Q3 24 | 9.8% | 1.5% |
| Q2 26 | 1.55× | — | ||
| Q1 26 | 1.03× | — | ||
| Q4 25 | 1.03× | 2.98× | ||
| Q3 25 | 9.57× | 9.43× | ||
| Q2 25 | 1.47× | -0.45× | ||
| Q1 25 | 1.91× | 2.20× | ||
| Q4 24 | 1.57× | 3.32× | ||
| Q3 24 | 5.59× | 1.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DLB
| Licensing | $372.2M | 94% |
| Products and services | $23.4M | 6% |
HIMS
Segment breakdown not available.
